Bolt Biotherapeutics, Inc. Increase (Decrease) in Other Noncurrent Liabilities
Bolt Biotherapeutics, Inc. (BOLT) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2026-08-11
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-06-30 was -$26.00K, a 2700.00% decline year-over-year.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2026-03-31 was $26.00K, a 80.30% decline year-over-year.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-12-31 was -$1.00K.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $0.00.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2025 was $132.00K.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$43.00K, a 4400.00% decline from fiscal 2023.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2023 was $1.00K.
- Bolt Biotherapeutics, Inc. increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$164.00K, a 4200.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | -$1.00K derived: sum of 3 quarters · filed 2026-08-11 | -$1.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $26.00K 10-Q · filed 2026-05-12 | $25.00K derived: sum of 2 quarters · filed 2026-05-12 | $25.00K derived: sum of 3 quarters · filed 2026-05-12 | $26.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$1.00K derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $132.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.00K derived: sum of 2 quarters · filed 2026-08-11 | $133.00K 10-Q · filed 2025-11-12 | $133.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $133.00K 10-Q · filed 2026-08-11 | $133.00K derived: sum of 3 quarters · filed 2026-08-11 | $133.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $132.00K 10-Q · filed 2026-05-12 | $132.00K derived: sum of 2 quarters · filed 2026-05-12 | $132.00K derived: sum of 3 quarters · filed 2026-05-12 | $132.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | -$43.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$43.00K 10-Q · filed 2025-11-12 | -$43.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$43.00K 10-Q · filed 2025-08-14 | -$43.00K derived: sum of 3 quarters · filed 2025-08-14 | -$43.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$43.00K 10-Q · filed 2025-05-12 | -$43.00K derived: sum of 2 quarters · filed 2025-05-12 | -$43.00K derived: sum of 3 quarters · filed 2025-05-12 | -$43.00K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $0.00 derived: sum of 2 quarters · filed 2025-03-24 | $0.00 derived: sum of 3 quarters · filed 2025-03-24 | $1.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $1.00K 10-Q · filed 2024-11-12 | -$157.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.00K 10-Q · filed 2024-08-13 | -$157.00K derived: sum of 3 quarters · filed 2024-08-13 | -$157.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-14 | -$157.00K derived: sum of 2 quarters · filed 2024-05-14 | -$157.00K derived: sum of 3 quarters · filed 2024-05-14 | -$159.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$158.00K derived: sum of 2 quarters · filed 2024-03-21 | -$160.00K derived: sum of 3 quarters · filed 2024-03-21 | -$164.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.00K derived: sum of 2 quarters · filed 2023-11-09 | -$6.00K 10-Q · filed 2023-11-09 | -$4.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$6.00K 10-Q · filed 2023-08-07 | -$4.00K derived: sum of 3 quarters · filed 2023-08-07 | -$4.00K derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-11 | -$2.00K derived: sum of 2 quarters · filed 2023-05-11 | -$2.00K derived: sum of 3 quarters · filed 2023-05-11 | -$2.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $2.00K derived: sum of 2 quarters · filed 2023-03-29 | $2.00K derived: sum of 3 quarters · filed 2023-03-29 | $4.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $2.00K 10-Q · filed 2022-11-10 | $5.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.00K 10-Q · filed 2022-08-10 | $5.00K derived: sum of 3 quarters · filed 2022-08-10 | $166.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-12 | $5.00K derived: sum of 2 quarters · filed 2022-05-12 | $166.00K derived: sum of 3 quarters · filed 2022-05-12 | $165.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $164.00K derived: sum of 2 quarters · filed 2022-03-30 | $163.00K derived: sum of 3 quarters · filed 2022-03-30 | $171.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $161.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $160.00K derived: sum of 2 quarters · filed 2021-11-09 | $168.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $7.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $8.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |